serena williams husband glp 1 on Her Weight Loss Journey With a GLP-1 Serena Williams has officially entered

The math is straightforward

metformin 1000 mg BID led to conflicting results on hyperandrogenism

RECENT GUIDANCE ON THE USE OF GLP-1 RAs IN PATIENTS WITH T2D In consideration of recently reported cardiovascular and renal outcome data, multiple organizations have published updated guidance over the last several years regarding the use of glucose-lowering agents in patients with T2D to mitigate cardiovascular and renal risks

Expect more lawsuits to be filed in the coming weeks and months as this litigation grows

Tirzepatide is newer, with FDA approval for weight loss (as Zepbound) coming in late 2023

Results vary based on consistency and ongoing care